Integene International Company
Integene International LLC. is a privately held Florida Corporation. The Company has developed platform technology for diabetes and it's complications. Targets include Peripheral Artery Disease (PAD) Obesity and Hyperglycemia. Integene International has developed a unique protocol GenstemX for the treatment of Ischemic diseases. Primary patented treatment is for Criticial Lower Limb Ischemia (CLI). The combined gene and stem cell treatment has proven successful in pre-clinical testing.
Industry:
Biomarkers for Longevity
Headquarters:
Miami, Florida, United States
Zip:
1-10
Founded Date:
2012-01-01
Employees Number:
1-10
Acquisitions Number:
1
Investors Number:
300000
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Venture - Series Unknown
Last Funding Type:
mgold@integene-int.com
Register and Claim Ownership